Skip to main content Deutsch

Funded Projects

"Pre-clinicAl Ion beam Research – PAIR", Doc.funds.connect awarded by FWF, Project Lead at MedUni Wien D. Georg; additional faculty from MedUni Vienna: B. Knäusl, J. Loizou (Department of Medicine I, Institute of Cancer Research) and T. Helbich (Department of Biomedical Imaging and Image-guided Therapy)

"Real-Time adaptive proton therapy of cancer – RAPTOR", Innovative Training Network (ITN) project awarded by EC, Project Lead at MedUni Wien D. Georg and B. Knäusl

„Tailored AXIllary Surgery with or without axillary lymph node dissection followed by radiotherapy in patients with clinically node-positive breast cancer (TAXIS). A multicenter randomized open labeled phase III trial“ Project funded by SAKK/ABCSG; Project leader: D. Kauer-Dorner (Principal Investigator: C. Singer, MedUni Vienna, Department of Obstetrics and Gynecology, Division of General Gynecology and Gynecologic Oncology; R. Exner, MedUni Vienna, Department of Surgery)

A Phase III, Randomized, Open-label Study to Evaluate Pembrolizumab as Neoadjuvant Therapy and in Combination With Standard of Care as Adjuvant  Therapy for Stage III-IVA Resectable Locoregionally Advanced Head and Neck Squamous CellCarcinoma (LA HNSCC) – Kurztitel  MK-3475-689 LAHNSCC“ G. Altorjai  (Principal Investigator Univ.-Kl. für Inn. Med. I, Th. Füreder)

„Image guided intensity modulated External beam radiochemotherapy and MRI based adaptive Brachytherapy in locally advanced CErvical cancer“ - EMBRACE studies“; Project funded by Nucletron; Project leader: C. Kirisits

"Structural and functional characterization of SPOC domains" FWF stand-alone grant, PI Dea Slade

"Proton and carbon ion response studies for chondrosarcoma – going beyond current radiobiological standards with 3D models", Project Leader Physics D. Georg (Project leader Biology and principal investigator B. Lohberger)

Image guided particle therapy of uveal melanoma with a multiport beam arrangement – IMPACTOR“ D. Georg

„A multi-centre, open-label, single-arm, dose-finding phase I/II study to evaluate safety, tolerability, dosing schedule, and preliminary efficacy of  carrier-added 4-L-[131I]iodo-phenylalanine (131I-IPA), administered as single or repetitive injections in patients with recurrent glioblastoma multiforme (GBM), concomitantly to 2nd line external radiation therapy  (XRT) - IPAX-1Study“ K. Dieckmann (Principal Investigator Univ.-Kl. für Radioonkologie und Nuklearmedizin, Klinische Abtlg. für Nuklearmedizin T. Traub-Weidinger)

"The regulation of dynamic interactions between PARG and PCNA" FWF stand-alone grant; PI Dea Slade

"Evidence-based decision-making in image-guided brachytherapy (EviGuide)" clinical research grant by the Austrian Science Fund (FWF) , PI Nicole Eder-Nesvacil

„Individualized Adaptive Radiotherapy in Cervix Cancer - EMBRACE II“ Project funded by Nucletron

"AGMT_HNO-2: Randomisierte Phase II Pilot Studie: Induktionstherapie mit  Docetaxel, Cisplatin und Cetuximab versus  Docetaxel, Cisplatin und 5 FU gefolgt Kopf-Hals Tumoren – Proj.Nr.: HNO-2", G. Altorjai